| Design Therapeutics, Inc. DSGN | $26.3M | 11.55 | 6.53M | 0% | +$0 | 7.22 | |
| Nkarta, Inc. NKTX | $36.03M | 4.73 | 3.33M | +150% | +$21.62M | 9.9 | |
| Arcellx, Inc. ACLX | $163.21M | 4.39 | 2.35M | -25.42% | -$55.64M | 44.83 | |
ARS Pharmaceuticals, Inc. SPRY | $41.01M | 4.14 | 4.01M | 0% | +$0 | 11.26 | |
Mineralys Therapeutics, Inc. MLYS | $26.04M | 4.06 | 2.02M | +12.38% | +$2.87M | 7.15 | |
| CRISPR Therapeutics AG CRSP | $71.5M | 1.24 | 1.05M | New | +$71.5M | 19.64 |